IP Library › Assignment 039008/0274
Patent Assignment
Reel/Frame 039008/0274

Assignment of Assignor's Interest

Recorded: 2016-06-24 Pages: 8
Assignors
POLLOCK, ROY M.
Executed: 2016-02-04
DAIGLE, SCOTT R.
Executed: 2015-11-12
Assignee
EPIZYME, INC.
400 TECHNOLOGY SQUARE, 4TH FLOOR, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties (3)
Methods for Treating Cancer
DOT1L Inhibitors for Use in the Treatment of Leukemia
Application: 14/654,125 →
Publication: US 2015/0342979
Methods for Treating Cancer
Application: 61/745,294 →
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 4, 2014
From: POLLOCK, ROY M.; DAIGLE, SCOTT R.
To: EPIZYME, INC.
Reel/Frame 032137/0549 →
Security Interest Nov 19, 2019
From: EPIZYME, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 051057/0848 →
Termination and Release of Security Interest in Patents at Reel/Frame: 051057/0848 Aug 13, 2022
From: BIOPHARMA CREDIT PLC
To: EPIZYME, INC.
Reel/Frame 061165/0501 →